ViaDerma Inc (VDRM)

[Mistral]

Of course I'm serious. The Annual Report with Disclosures contains very important information. In January 2017, Otiko signed an Addendum to his non-exclusive patent license agreement with Howard Phillips that promises he wouldn't lie.

In the news release, Otiko states:

The Company is in the final testing phase before manufacturing its Patent Pending (provisional patent number 62433964) topical antibiotic product, Viabecline.

Otiko does not own Viabecline! Why is Otiko giving a provisional application number for Viabecline when Viabecline is a Phillips Company product that is based on the Phillips/Keough patent-pending transdermal delivery system, and that Otiko has a non-exclusive license to manufacture and sell?

Otiko agreed to stop misleading and just broke that January 2017 agreement. Phillips can pull Otiko's non-exclusive agreement for violation of the Addendum and Keough can use this news release and Addendum as further evidence of Otiko's deceitful behavior.

https://www.pacermonitor.com/case/21120838/Keough_v_Otiko_et_al

Are you serious? How about Viabecline in final testing phase for manufacturing. They're just about ready to role. This is huge news!